Abstract
Administration of large doses of cimetidine for 45 days to rats decreases the weight of the prostate and seminal vesicles without affecting the testicles. The decrease in weight is due to a marked regression in the prostate of both epithelial and stromal tissue.
Treatment with cimetidine also causes an increase in the plasma testosterone level without modifying the plasma values of LH and prolactin. The mechanism of action of cimetidine is discussed. In presence of high levels of testosterone, cimetidine depresses structures such as the prostate and seminal vesicles, which are sensitive to androgens, but does not depress the weight or change the histology profile of the testicles, which are also rich in androgen receptors. Perhaps cimetidine binds to androgen receptors differently in the prostate and in the testicles because of differences in receptor structure or more probably, cimetidine interacts with zinc metal ion essential to prostate growth and androgen action by lowering zinc prostatic levels and consequently depresses the prostatic weight.
Similar content being viewed by others
References
R. M. Brimblecombe, A. M. Duncan, G. J. Durant, J. C. Emmett, C. R. Ganellin, G. B. Leslie and M. E. Parson,Characterization and development of cimetidine as a histamin H 2 -receptor antagonist, Gastroenterology74, 339–347 (1978).
S. J. Winters, J. L. Banks, and D. L. Loriaux,Cimetidine is an antiandrogen in the rat, Gastroenterology76, 504–508 (1979).
J. W. Funder and J. E. Mercer,Cimetidine, a histamine H 2 receptor antagonist, occupies androgen receptor, J. Clin. Endocrinol. Metab.48, 189–191 (1979).
P. C. Sivelle, A. M. Underwood and J. A. Jelly,The effects of histamine H 2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro, Biochem. Pharmacol.31, 677–684 (1982).
R. P. Walt, S. J. La Brooy, A. Augerinos, T. Oehr, A. Riley and J. J. Misiewcz,Investigations on the penetration of ranitidine into the cerebrospinal fluid and comparison of the effects of ranitidine and cimetidine on male sex hormones. InProceedings of the First International Symposium on Ranitidine. (Ed. J. J. Misiewicz and K. Fr. Sewing) Scand. J. Gastroenterol.16, (69), 19–23 (1981).
H. G. Bohnet, M. Greiwe, J. P. Hanker, C. Aragona and H. P. G. Schneider,Effects of cimetidine on prolactin, LH and sex hormones in male and female volunteers, Acta Endocrinol.88, 428–434 (1978).
N. R. Peden, E. J. S. Boyd, C. K. Browning, J. H. B. Saunders and K. G. Wormsly,Effects of two histamine H 2 -receptor blocking drugs on basal levels of gonadotrophins, prolactin, testosterone and oestradiol — 17 B during treatment of duodenal ulcer in male patients, Acta Endocrinol.96, 564–568 (1981).
D. H. Van Thiel, J. S. Gavaler, W. I. Smith and R. Gwendolyn,Hypothalamic-pituitary-gonadal dysfunction in man using cimetidine, New Engl. J. Med.300, 1012–1015 (1979).
J. Apgar,Zinc and reproduction, Ann. Rev. Nutr.5, 43–68 (1985).
A. W. Root, G. Duckett, M. Sweetland and E. O. Reiter,Effects of zinc deficiency upon pituitary function in sexually mature and immature male rats, J. Nutr.109, 958–964 (1979).
A. G. E. Pearse,Histochemistry, Churchill Livingstone, London 1977.
B. H. Jaffe and D. Bejrman,Methods of hormone radioimmunoassay, II Edition, Academic Press, New York 1979.
G. D. Niswender, A. R. Midgley Jr, S. E. Monroe and L. E. Reichert,Radioimmunoassay for rat luteinizing hormone with antiovine LH serum and ovine LH 131 I, Proc. Soc. Exp. Biol. Med.128, 807–811 (1986).
G. D. Niswender, C. L. Chen, A. R. Midgley, Jr., J. Meites and S. Ellis,Radioimmunoassay for rat prolactin, Proc. Soc. Exp. Biol. Med.130, 793–797 (1969).
R. W. Boesel, R. W. Kliper and S. A. Shain,Androgen regulation of androgen receptor content and distribution in the ventral and dorsolateral prostate of aging A×C rats, Steroids35, 157–177 (1980).
B. M. Sanborn, A. Steinberger, M. L. Mestrich and E. Steinberger,Androgen binding sites in testis cell fractions as measured by a nuclear exchange assay, J. Steroid. Biochem.6, 1459–1465 (1975).
J. A. Bell, A. J. Gower, L. E. Martin, G. N. C. Mills and W. P. Smith,Interactions of H 2 -receptor antagonists with drugmetabolizing enzymes, Biochem. Soc. Trans.9, 113–114 (1981).
D. A. Henry and M. J. S. Langman,The effects of H 2 -receptor antagonists on hepatic drug metabolism. InProceedings of the First International Symposium on Ranitidine. (Ed. J. J. Misievwicz and K. Fr. Sewing) Scand. J. Gastroenterol.16, (69) 85–87 (1981).
O. A. Lea, E. M. Wilson and F. S. French,Characterization of different forms of the androgen receptor, Endocrinology105, 1350–1360 (1979).
K. W. Chung, S. Y. Kim, W. Chan and O. M. Rennert,Androgen receptors in ventral prostate glands of zinc-deficient rats, Life Sci.38, 351–356 (1986).
A. Leake, G. D. Chrisholm, A. Busuttil and F. K. Habib,Subcellular distribution of zinc in the benign and malignant human prostate: evidence for a direct zinc androgen interaction, Acta Endocrinologica105, 281–286 (1984).
G. Sinqui, R. F. Morfin, J. F. Charles and H. H. Floch,Testosterone metabolism of human prostates with benign iperplasia: effects of zinc, cadmium and other bivalent cations, J. Steroid Biochem.20, 773–780 (1984).
H. Allgayer and G. Baumgartner,Studies on the in vitro interactions of cimetidine with commercial antacid preparations and chemically pure components, Arzneim-Forsch.34(II), 870–871 (1984).
F. Akrivos, M. J. Blais, J. Hoffelt and G. Berton,An assessment of the physiological significance of cimetidine interactions with copper and zinc in biofluids as based on the computer simulated distribution of the involved complexes at the therapeutic levels of the drug, Agents and Actions15, 649–659 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pinelli, P., Trivulzio, S., Cocchi, D. et al. Antiprostatic effect of cimetidine in rats. Agents and Actions 22, 197–201 (1987). https://doi.org/10.1007/BF02009046
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02009046